# AI-Driven-Site-Feasibility
The AI-Driven Site Feasibility Assessment tool predicts the suitability of clinical trial sites by analyzing historical performance (e.g., enrollment rates, protocol deviations), trial requirements (e.g., therapeutic area, patient demographics), and external factors (e.g., disease prevalence, geographic data). 
